Clover Health will release its Q4 2025 financial results and host a webcast on February 26, 2026.
Quiver AI Summary
Clover Health Investments, Corp. will release its financial results for the fourth quarter and full year of 2025 after the market closes on February 26, 2026. Following the release, the company's management will host a webcast at 5:00 p.m. Eastern Time to discuss the financial performance and business updates. Interested participants can register for the webcast or access it through the Investor Relations section of Clover Health's website. Clover Health focuses on providing accessible healthcare to Medicare recipients, particularly seniors, through its software platform, Clover Assistant, which enhances clinical decision-making and health outcomes. The company also offers PPO and HMO Medicare Advantage plans and aims to extend its technology's benefits to a broader healthcare audience through its subsidiary, Counterpart Health.
Potential Positives
- Clover Health will provide its Fourth Quarter and Full Year 2025 financial results, which indicates transparency and a commitment to keeping investors informed.
- The live webcast presentation scheduled for February 26, 2026, allows for real-time engagement with management, fostering investor relations and trust.
- The company's focus on utilizing technology, such as the Clover Assistant platform, highlights its innovative approach to improving healthcare outcomes and managing chronic diseases, potentially attracting interest from investors and partners in the healthcare sector.
Potential Negatives
- The timing of the press release, which announces the financial results will be disclosed after market hours, may suggest that there could be unfavorable news that management is attempting to minimize immediate market impact.
- The absence of specific financial forecasts or metrics in this release could indicate poor performance expectations, potentially leading to investor skepticism.
FAQ
When will Clover Health announce its financial results?
Clover Health will release its financial results on Thursday, February 26, 2026, after market close.
What time is the Clover Health earnings webcast?
The Clover Health earnings conference call will be at 5:00 p.m. Eastern Time on February 26, 2026.
How can I access the Clover Health earnings webcast?
You can register for the webcast at https://clover-health-q425-earnings-call.open-exchange.net/.
Where can I find the archived Clover Health earnings webcast?
The archived webcast will be available on Clover Health’s Investor Relations page for 12 months.
What services does Clover Health provide for Medicare patients?
Clover Health offers PPO and HMO Medicare Advantage plans focusing on improving healthcare access for seniors.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$CLOV Insider Trading Activity
$CLOV insiders have traded $CLOV stock on the open market 12 times in the past 6 months. Of those trades, 4 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $CLOV stock by insiders over the last 6 months:
- VIVEK GARIPALLI has made 2 purchases buying 446,980 shares for an estimated $998,996 and 0 sales.
- JAMIE L. REYNOSO (CEO, Medicare Advantage) has made 0 purchases and 8 sales selling 72,260 shares for an estimated $223,436.
- ANNA U LOENGARD has made 2 purchases buying 26,500 shares for an estimated $68,755 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CLOV Revenue
$CLOV had revenues of $496.6M in Q3 2025. This is an increase of 50.05% from the same period in the prior year.
You can track CLOV financials on Quiver Quantitative's CLOV stock page.
$CLOV Hedge Fund Activity
We have seen 82 institutional investors add shares of $CLOV stock to their portfolio, and 98 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BANK OF AMERICA CORP /DE/ removed 3,879,613 shares (-96.7%) from their portfolio in Q3 2025, for an estimated $11,871,615
- MARSHALL WACE, LLP removed 3,523,047 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $10,780,523
- RENAISSANCE TECHNOLOGIES LLC removed 2,780,900 shares (-26.5%) from their portfolio in Q3 2025, for an estimated $8,509,554
- DIVISADERO STREET CAPITAL MANAGEMENT, LP added 2,768,088 shares (+inf%) to their portfolio in Q3 2025, for an estimated $8,470,349
- CITADEL ADVISORS LLC removed 2,042,721 shares (-57.9%) from their portfolio in Q3 2025, for an estimated $6,250,726
- QUBE RESEARCH & TECHNOLOGIES LTD removed 1,746,937 shares (-82.6%) from their portfolio in Q3 2025, for an estimated $5,345,627
- GOLDMAN SACHS GROUP INC removed 1,494,774 shares (-63.3%) from their portfolio in Q3 2025, for an estimated $4,574,008
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CLOV Analyst Ratings
Wall Street analysts have issued reports on $CLOV in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 11/06/2025
To track analyst ratings and price targets for $CLOV, check out Quiver Quantitative's $CLOV forecast page.
$CLOV Price Targets
Multiple analysts have issued price targets for $CLOV recently. We have seen 2 analysts offer price targets for $CLOV in the last 6 months, with a median target of $3.35.
Here are some recent targets:
- Richard Close from Canaccord Genuity set a target price of $3.7 on 01/20/2026
- Jonathan Yong from UBS set a target price of $3.0 on 08/06/2025
Full Release
WILMINGTON, Del., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial results after the market closes on Thursday, February 26, 2026. The Company’s management will host a webcast presentation at 5:00 p.m. Eastern Time on the same day to discuss the company’s business and financial performance for the quarter.
Fourth Quarter and Full Year 2025 Conference Webcast Details:
- What : Clover Health’s Fourth Quarter and Full Year 2025 Earnings Conference Call
- When : Thursday, February 26, 2026, at 5:00 p.m. Eastern Time
-
Webcast
: To access the webcast, you may register at
https://clover-health-q425-earnings-call.open-exchange.net/
.
A live and archived webcast of the conference call will also be accessible from the Investor Relations section of Clover Health’s website at https://investors.cloverhealth.com/ for 12 months.
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on
Medication Adherence
,
Congestive Heart Failure
,
Chronic Obstructive Pulmonary Disease
, and in
Underserved Populations
as well as the earlier identification and management of
Diabetes
and
Chronic Kidney Disease
.
Investor Relations:
Ryan Schmidt
[email protected]
Press Inquiries:
[email protected]
